Challenge No 2: Missing industry hubs
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...Read more
Aussies to get breast cancer treatment analysis
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2014
Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...Read more
Cancer Therapeutics reveals new targeted drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...Read more
Australia approves Hospira's biosimilar
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2015
Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...Read more
Trial of cancer killing virus-based drug is a success
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013
Singapore: Viralytics Biotech and Amgen, released top line results on its oncolytic virotherapy investigational product...Read more
F&S: Double-digit growth for APAC pharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Dec, 2012
Singapore: The pharmaceuticals industry in the Asia Pacific is thriving on the back of escalating population and increa...Read more
BSA-CMR Survey: APAC CROs stick to an average of 50 clients
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Phylogica, Janssen expand drug discovery tie-up
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013
Singapore: Phylogica, a leading Australian peptide drug discovery company, is expanding its collaboration with Janssen B...Read more
New antibody-based drug to cure diabetes
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...Read more
Hot investment destinations in Asia
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2012
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...Read more
QrxPharma, Aesica expand drug delivery technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Australia-based QRxPharma has collaborated with Aesica Formulation Development for the world-wide promotion o...Read more
New medtech market infographic published
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...Read more
3M, Aussie firm collaborate to develop vaccine technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2013
Singapore: Australia based Ascend Biopharmaceuticals has collaborated with 3M Drug Delivery Systems to evaluate 3M's Tol...Read more
Fovia to image cancer cells using HD volume
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2013
Singapore: Fovia Medical, a world leader in volume rendering technology, and Contrast Imaging, a leading Australian pro...Read more
BioDiem, Griffith University join hands for antimicrobial compound
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Singapore: Australian infectious disease therapy development company BioDiem signed an agreement with Griffith Universi...Read more
pSivida enrols first patient in Uveitis trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012
Singapore: pSivida, a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye di...Read more
Australian CRO expands its operations in HongKong
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2015
Singapore: Australia-based contract research organization, Novotech, recently announced that it has expanded its Hong Ko...Read more
Cochlear electrode gets US FDA approval
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012
Singapore: Cochlear has received the US Food & Drug Administration (FDA) approval for its Nucleus CI422 with Slim St...Read more